KTX-951 is a PROTAC designed to selectively degrade IRAK4, demonstrating effective performance in cellular assays. This compound exhibits notable oral bioavailability in preclinical models, indicating its potential for effective systemic delivery. Additionally, KTX-951 shows promise in anticancer applications due to its mechanism of action. Reagent-grade; for laboratory research purposes only.
Products > PROTAC, Molecular glue > Degraders
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.